title: Rates of flow of technetium 99m--labeled human serum albumin from peripheral injection sites to sentinel lymph nodes.
abstract: BACKGROUND
  The new technique of sentinel lymphadenectomy for cutaneous melanoma provided us with a unique opportunity to quantitate the rates of lymphatic flow in afferent lymphatics.
  
  
  METHODS
  Seventeen melanoma patients underwent preoperative lymphoscintigraphy with technetium 99m-human serum albumin (HSA). The time and distance between the injection site and the sentinel lymph node (LN) were recorded. By comparison, lymphatic flow rates between footpad, popliteal LN, femoral LN, and systemic blood were measured in 60 female mice (C57BL/6) after footpad injection of 99mTc-HSA.
  
  
  RESULTS
  The rate of lymphatic flow to 14 axillary, four inguinal, one popliteal, and one parotid sentinel LNs averaged 10.4 +/- 7.3 cm/min. In contrast, the lymphatic flow rate between the footpad and the popliteal LN in mice (analogous to the sentinel LN in human beings) averaged 1.33 +/- 0.52 cm/min. There was a marked delay in the passage of radionuclide through the popliteal LN with consequent slowing of the rate of flow between the popliteal and femoral LNs to 0.22 cm/min.
  
  
  CONCLUSIONS
  Lymphatic flow to the sentinel LN occurs rapidly from both human skin and murine footpads. This information might be helpful in planning the timing of the incision after vital blue dye injection for identifying the sentinel LN.
authors.affiliation: Department of Surgery, Henry Ford Health System, Detroit, Michigan, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Nathanson
authors.forename: L
authors.initials: L
authors.lastname: Nelson
authors.forename: K C
authors.initials: KC
authors.lastname: Karvelis
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008196:Lymph / Q000502:physiology*; D008545:Melanoma / Q000473:pathology / Q000503:physiopathology*; D008546:Melanoma, Experimental / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D019275:Radiopharmaceuticals; D012878:Skin Neoplasms / Q000473:pathology / Q000503:physiopathology*; D013668:Technetium Tc 99m Aggregated Albumin; D013997:Time Factors
chemical_list: D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin